ongitudinal study of immune response and epigenetics in acute LongCovid syndrome secondary to COVID-19 disease.
Recruiting
- Conditions
- post-COVID-19 syndromeU09.9Post COVID-19 condition, unspecified
- Registration Number
- DRKS00027314
- Lead Sponsor
- Klinik I für Innere MedizinUniversitätsklinikum Köln (AöR)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Good physical condition (Karnofsky index =80%).
Previous laboratory diagnostic evidence of SARS-CoV-2 infection.
Current existing LongCovid syndrome.
Exclusion Criteria
Hemoglobin <10 g/dL
Symptomatic heart disease (e.g., heart failure NYHA =II, coronary artery disease)
previous myocardial infarction
COPD Stage GOLD III-IV
Body weight less than 45kg
<8 weeks (men) or <12 weeks (women) since last blood collection of =500 ml
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of characteristic blood markers in LongCovid syndrome.
- Secondary Outcome Measures
Name Time Method not applicable